[go: up one dir, main page]

El-Obeild et al., 1987 - Google Patents

Pirenzepine dihydrochloride

El-Obeild et al., 1987

View PDF
Document ID
1464888887659907335
Author
El-Obeild H
Babhair S
Al-Badr A
Publication year
Publication venue
Analytical Profiles of Drug Substances

External Links

Snippet

Publisher Summary This chapter explains the nomenclature, synthesis, methods of analysis, and pharmacology of pirenzepine dihydrochloride. Pirenzepine is a tricyclic compound, but its physico-chemical properties differ considerably from those of other tricyclic compounds …
Continue reading at www.researchgate.net (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation; Therapies using these preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S514/00—Drug, bio-affecting and body treating compositions

Similar Documents

Publication Publication Date Title
Yellin et al. ICI 125,211: a new gastric antisecretory agent acting on histamine H2-receptors
US5290784A (en) Aconitane derivatives used as a medication to treat addiction
US5604198A (en) Method to enhance permeability of the blood/brain blood/nerve barriers to therapeutic agents
US4508726A (en) Treatment of panic disorders with alprazolam
DE69714253T2 (en) NITROGEN OXIDIZING PREPARATION FOR REDUCING THE TOXICITY OF ACTIVE SUBSTANCES
JP3115119B2 (en) Tramadol N-oxide materials, enantiomers and compositions thereof, and uses thereof
PT1480961E (en) Glutaminyl based dpiv inhibitors
IL123601A (en) Pharmaceutical compositions containing epinastine for the treatment of pain
FI74705B (en) FREQUENCY REFRIGERATION FOR NEW CRYSTALS BENSOTIAZINDIOXIDSALTER.
GB2271059A (en) Pharmaceutical compositions comprising aconitane derivatives
GB2192541A (en) Bromocriptine
GB2170707A (en) An immuno-regulator
EP0365044A2 (en) Novel pharmaceutical use of (NVA)2-cyclosporine
IE852697L (en) Dipeptides for treatment of sclerosis
Kornguth et al. Binding of psychotropic drugs to isolated α1-acid glycoprotein
El-Obeild et al. Pirenzepine dihydrochloride
CA2261662A1 (en) Sorbefacients
US6488967B1 (en) Gastric acid secretion
US5019558A (en) Method for treating memory disturbances using arginine aspartate
Kleinert et al. Cardiovascular actions of the primate-selective renin inhibitor, A-62198.
DE2739440A1 (en) PENTAPEPTIDE AND MEDICINAL PRODUCTS CONTAINING IT
JPS60172929A (en) Agent for alleviating amnesia
EP1685134B1 (en) Novel chelidonine derivatives, methods for the production thereof, and use thereof for producing pharmaceutical agents
TAKEUCHI et al. Effects of S‐0509, a novel CCKB/gastrin receptor antagonist, on acid secretion and experimental duodenal ulcers in rats
DE2628006C2 (en) Tridecapeptide, process for its preparation and its use